Evaluation of the immune-profiling for patients participating in Phase Ib/II Study of BBI608 in Combination with Pembrolizumab and the relationship between the immune-profiling and efficacy using paired biopsies and peripheral blood.
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2639746
下载链接
链接失效反馈官方服务：
资源简介：
Primary outcome(s): Evaluation of the immune-profiling.
创建时间：
2016-10-15
